199 related articles for article (PubMed ID: 17018259)
21. Resorufin: a lead for a new protein kinase CK2 inhibitor.
Sandholt IS; Olsen BB; Guerra B; Issinger OG
Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
[TBL] [Abstract][Full Text] [Related]
22. From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.
Georgakis GV; Younes A
Expert Rev Anticancer Ther; 2006 Jan; 6(1):131-40. PubMed ID: 16375650
[TBL] [Abstract][Full Text] [Related]
23. Thyroid-hormone-dependent activation of the phosphoinositide 3-kinase/Akt cascade requires Src and enhances neuronal survival.
Cao X; Kambe F; Yamauchi M; Seo H
Biochem J; 2009 Nov; 424(2):201-9. PubMed ID: 19747164
[TBL] [Abstract][Full Text] [Related]
24. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
25. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
Lee DH; Szczepanski MJ; Lee YJ
J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
[TBL] [Abstract][Full Text] [Related]
26. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
27. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
[TBL] [Abstract][Full Text] [Related]
29. Targeting the PI3K-Akt pathway in kidney cancer.
Park JY; Lin PY; Weiss RH
Expert Rev Anticancer Ther; 2007 Jun; 7(6):863-70. PubMed ID: 17555396
[TBL] [Abstract][Full Text] [Related]
30. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
31. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells.
Bastien J; Plassat JL; Payrastre B; Rochette-Egly C
Oncogene; 2006 Mar; 25(14):2040-7. PubMed ID: 16288212
[TBL] [Abstract][Full Text] [Related]
32. Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway.
Crowder RJ; Ellis MJ
Breast Cancer Res; 2005; 7(5):212-4. PubMed ID: 16168140
[TBL] [Abstract][Full Text] [Related]
33. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis.
Cui Y; Lu P; Song G; Liu Q; Zhu D; Liu X
Food Chem Toxicol; 2016 Jun; 92():26-37. PubMed ID: 27032576
[TBL] [Abstract][Full Text] [Related]
34. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor.
Yim H; Lee YH; Lee CH; Lee SK
Planta Med; 1999 Feb; 65(1):9-13. PubMed ID: 10083837
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity.
Ponce DP; Maturana JL; Cabello P; Yefi R; Niechi I; Silva E; Armisen R; Galindo M; Antonelli M; Tapia JC
J Cell Physiol; 2011 Jul; 226(7):1953-9. PubMed ID: 21506126
[TBL] [Abstract][Full Text] [Related]
36. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
Barata JT
Adv Enzyme Regul; 2011; 51(1):37-49. PubMed ID: 21035501
[TBL] [Abstract][Full Text] [Related]
37. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity.
Lee KS; Park JH; Lee S; Lim HJ; Jang Y; Park HY
Biochem Biophys Res Commun; 2006 Jul; 346(1):83-8. PubMed ID: 16759638
[TBL] [Abstract][Full Text] [Related]
38. Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway.
Powis G; Ihle N; Kirkpatrick DL
Clin Cancer Res; 2006 May; 12(10):2964-6. PubMed ID: 16707590
[No Abstract] [Full Text] [Related]
39. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
40. [Casein kinase 2, the versatile regulator of cell survival].
Volodina IuL; Shtil' AA
Mol Biol (Mosk); 2012; 46(3):423-33. PubMed ID: 22888632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
